{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:45:01Z","timestamp":1791020701712,"version":"4.1.0"},"reference-count":38,"publisher":"Pharmaceutical Society of Japan","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2020,5,1]]},"DOI":"10.1248\/bpb.b19-00720","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T22:07:17Z","timestamp":1588284437000},"page":"767-773","source":"Crossref","is-referenced-by-count":5,"title":["Effects of <i>Gentiana delavayi<\/i> Flower Extract on APP Processing in APP\/PS1 CHO Cells"],"prefix":"10.1248","volume":"43","author":[{"given":"Min","family":"Yang","sequence":"first","affiliation":[{"name":"College of Pharmacy and Chemistry, Dali University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-yi","family":"Zhou","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Shanghai Jiao Tong University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-feng","family":"Li","sequence":"additional","affiliation":[{"name":"College of Pharmacy and Chemistry, Dali University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-yun","family":"Yang","sequence":"additional","affiliation":[{"name":"College of Pharmacy and Chemistry, Dali University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yin","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Shanghai Jiao Tong University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-hang","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Shanghai Jiao Tong University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-sheng","family":"Wang","sequence":"additional","affiliation":[{"name":"College of Pharmacy and Chemistry, Dali University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) C2019. Alzheimer\u2019s Disease International. \u201cWorld Alzheimer report 2019: attitudes to dementia.\u201d: \u2039https:\/\/www.alz.co.uk\/research\/world-report-2019\u203a."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Spires-Jones TL, Attems J, Thal DR. Interactions of pathological proteins in neurodegenerative diseases. Acta Neuropathol.<\/i>, 134<\/b>, 187\u2013205 (2017).","DOI":"10.1007\/s00401-017-1709-7"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Sathya M, Premkumar P, Karthick C, Moorthi P, Jayachandran KS, Anusuyadevi M. BACE1 in Alzheimer\u2019s disease. Clin. Chim. Acta<\/i>, 414<\/b>, 171\u2013178 (2012).","DOI":"10.1016\/j.cca.2012.08.013"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Haass C, Kaether C, Thinakaran G, Sisodia S. Trafficking and proteolytic processing of APP. Cold Spring Harb. Perspect. Med.<\/i>, 2<\/b>, a006270 (2012).","DOI":"10.1101\/cshperspect.a006270"},{"key":"5","unstructured":"5) Selkoe DJ. Alzheimer\u2019s disease: genes, proteins, and therapy. Physiol. Rev.<\/i>, 81<\/b>, 741\u2013766 (2001)."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Fu L, Sun Y, Guo Y, Chen Y, Yu B, Zhang H, Wu J, Yu X, Kong W, Wu H. Comparison of neurotoxicity of different aggregated forms of A\u03b240, A\u03b242 and A\u03b243 in cell cultures. J. Pept. Sci.<\/i>, 23<\/b>, 245\u2013251 (2017).","DOI":"10.1002\/psc.2975"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Verdurand M, Chauveau F, Daoust A, Morel AL, Bonnefoi F, Liger F, Berod A, Zimmer L. Differential effects of amyloid-beta 1\u201340 and 1\u201342 fibrils on 5-HT1A serotonin receptors in rat brain. Neurobiol. Aging<\/i>, 40<\/b>, 11\u201321 (2016).","DOI":"10.1016\/j.neurobiolaging.2015.12.008"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Diniz LP, Tortelli V, Matias I, Morgado J, B\u00e9rgamo AP, Melo HM, Seixas da Silva GS, Alves-Leon SV, De Souza JM, Ferreira ST, De Felice FG, Gomes FCA. Astrocyte transforming growth factor beta 1 protects synapses against A\u03b2 oligomers in Alzheimer\u2019s disease model. J. Neurosci.<\/i>, 37<\/b>, 6797\u20136809 (2017).","DOI":"10.1523\/JNEUROSCI.3351-16.2017"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Seixas da Silva GS, Melo HM, Lourenco MV, Lyra E Silva NM, De Carvalho MB, Alves-Leon SV, de Souza JM, Klein WL, da-Silva WS, Ferreira ST, De Felice FG. Amyloid-beta oligomers transiently inhibit AMP-activated kinase and cause metabolic defects in hippocampal neurons. J. Biol. Chem.<\/i>, 292<\/b>, 7395\u20137406 (2017).","DOI":"10.1074\/jbc.M116.753525"},{"key":"10","unstructured":"10) Koelsch G. BACE1 function and inhibition: implications of intervention in the amyloid pathway of Alzheimer\u2019s disease pathology. Molecules<\/i>, 22<\/b>, 1723 (2017)."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Ghosh AK, Osswald HL. BACE1 (beta-secretase) inhibitors for the treatment of Alzheimer\u2019s disease. Chem. Soc. Rev.<\/i>, 43<\/b>, 6765\u20136813 (2014).","DOI":"10.1039\/C3CS60460H"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Wu L, Feng X, Li T, Sun B, Khan MZ, He L. Risperidone ameliorated Abeta1-42-induced cognitive and hippocampal synaptic impairments in mice. Behav. Brain Res.<\/i>, 322<\/b> (Pt A), 145\u2013156 (2017).","DOI":"10.1016\/j.bbr.2017.01.020"},{"key":"13","unstructured":"13) Li Y, Wang J, Zhang S, Liu Z. Neprilysin gene transfer: a promising therapeutic approach for Alzheimer\u2019s disease. J. Neurosci. Res.<\/i>, 93<\/b>, 1325\u20131329 (2015)."},{"key":"14","unstructured":"14) Cummings J, Lee G, Mortsdorf T, Ritter A, Zhong K. Alzheimer\u2019s disease drug development pipeline: 2017. Alzheimers. Dement.<\/i>, 3<\/b>, 367\u2013384 (2017)."},{"key":"15","unstructured":"15) Cummings JL, Morstorf T, Zhong K. Alzheimer\u2019s disease drug-development pipeline: few candidates, frequent failures. Alzheimers Res. Ther.<\/i>, 6<\/b>, 37 (2014)."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Zheng H, Fridkin M, Youdim M. New approaches to treating Alzheimer\u2019s disease. Perspect. Medicin. Chem.<\/i>, 7<\/b>, 1\u20138 (2015).","DOI":"10.4137\/PMC.S13210"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Williams P, Sorribas A, Howes MJ. Natural products as a source of Alzheimer\u2019s drug leads. Nat. Prod. Rep.<\/i>, 28<\/b>, 48\u201377 (2011).","DOI":"10.1039\/C0NP00027B"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Grossberg GT. Cholinesterase inhibitors for the treatment of Alzheimer\u2019s disease: getting on and staying on. Curr. Ther. Res. Clin. Exp.<\/i>, 64<\/b>, 216\u2013235 (2003).","DOI":"10.1016\/S0011-393X(03)00059-6"},{"key":"19","unstructured":"19) Liu JL, Yuan YH, Chen NH. Comparative study on screening acetylcholinesterase inhibitors from different enzyme sources. Acta Neuropharmacol.<\/i>, 1<\/b>, 27\u201330 (2011)."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Yu F, Yu F, Li R, Wang R. Inhibitory effects of the Gentiana macrophylla<\/i> (Gentianaceae) extract on rheumatoid arthritis of rats. J. Ethnopharmacol.<\/i>, 95<\/b>, 77\u201381 (2004).","DOI":"10.1016\/j.jep.2004.06.025"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Hudecov\u00e1 A, Hasplov\u00e1 K, Miadokov\u00e1 E, Magdolenov\u00e1 Z, Rinna A, Collins AR, G\u00e1lov\u00e1 E, Vaculcikov\u00e1 D, Gregan F, Dusinsk\u00e1 M. Gentiana asclepiadea<\/i> protects human cells against oxidation DNA lesions. Cell Biochem. Funct.<\/i>, 30<\/b>, 101\u2013107 (2012).","DOI":"10.1002\/cbf.1822"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Shahat AA, Abdel-Azim NS, Pieters L, Vlietinck AJ. Isolation and NMR spectra of syringaresinol-\u03b2-D-glucoside from Cressa cretica.<\/i> Fitoterapia<\/i>, 75<\/b>, 771\u2013773 (2004).","DOI":"10.1016\/j.fitote.2004.05.008"},{"key":"23","unstructured":"23) Yang NY, Duan JA, Li P, Qian SH, Zhang J. Flavonoids from Glechoma longituba<\/i> (Nakai) Kupr. J. China Pharmaceut. Univ.<\/i>, 36<\/b>, 210\u2013212 (2005)."},{"key":"24","unstructured":"24) Barage SH, Sonawane KD. Amyloid cascade hypothesis: pathogenesis and therapeutic strategies in Alzheimer\u2019s disease. Neuropeptides<\/i>, 52<\/b>, 1\u201318 (2015)."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Thal DR, Walter J, Saido TC, Fandrich M. Neuropathology and biochemistry of abeta and its aggregates in Alzheimer\u2019s disease. Acta Neuropathol.<\/i>, 129<\/b>, 167\u2013182 (2015).","DOI":"10.1007\/s00401-014-1375-y"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Michalska P, Buendia I, Del Barrio L, Leon R. Novel multitarget hybrid compounds for the treatment of Alzheimer\u2019s disease. Curr. Top. Med. Chem.<\/i>, 17<\/b>, 1027\u20131043 (2017).","DOI":"10.2174\/1568026616666160927154116"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Yan R, Vassar R. Targeting the \u03b2 secretase BACE1 for Alzheimer\u2019s disease therapy. Lancet Neurol.<\/i>, 13<\/b>, 319\u2013329 (2014).","DOI":"10.1016\/S1474-4422(13)70276-X"},{"key":"28","unstructured":"28) Sakamoto K, Matsuki S, Matsuguma K, Yoshihara T, Uchida N, Azuma F, Russell M, Hughes G, Haeberlein SB, Alexander RC, Eketjall S, Kugler AR. BACE1 inhibitor lanabecestat (AZD3293) in a phase 1 study of healthy Japanese subjects: pharmacokinetics and effects on plasma and cerebrospinal fluid abeta peptides. J. Clin. Pharmacol.<\/i>, 57<\/b>, 1460\u20131471 (2017)."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Ellis CR, Tsai CC, Lin FY, Shen J. Conformational dynamics of cathepsin D and binding to a small-molecule BACE1 inhibitor. J. Comput. Chem.<\/i>, 38<\/b>, 1260\u20131269 (2017).","DOI":"10.1002\/jcc.24719"},{"key":"30","unstructured":"30) Turner RT 3rd, Koelsch G, Hong L, Castanheira P, Ermolieff J, Ghosh AK, Tang J. Subsite specificity of memapsin 2 (\u03b2-secretase): implications for inhibitor design. Biochemistry<\/i>, 40<\/b>, 10001\u201310006 (2001)."},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Steinfeld R, Reinhardt K, Schreiber K, Hillebrand M, Kraetzner R, Bruck W, Saftig P, Gartner J. Cathepsin D deficiency is associated with a human neurodegenerative disorder. Am. J. Hum. Genet.<\/i>, 78<\/b>, 988\u2013998 (2006).","DOI":"10.1086\/504159"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Ghosh AK, Tang J. Prospects of beta-secretase inhibitors for the treatment of Alzheimer\u2019s disease. ChemMedChem<\/i>, 10<\/b>, 1463\u20131466 (2015).","DOI":"10.1002\/cmdc.201500216"},{"key":"33","unstructured":"33) Eketj\u00e4ll S, Janson J, Kaspersson K, Bogstedt A, Jeppsson F, Falting J, Haeberlein SB, Kugler AR, Alexander RC, Cebers G. AZD3293: a novel, orally active BACE1 inhibitor with high potency and permeability and markedly slow off-rate kinetics. J. Alzheimers Dis.<\/i>, 50<\/b>, 1109\u20131123 (2016)."},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Lima RT, Sousa D, Paiva AM, Palmeira A, Barbosa J, Pedro M, Pinto MM, Sousa E, Vasconcelos MH. Modulation of autophagy by a thioxanthone decreases the viability of melanoma cells. Molecules<\/i>, 21<\/b>, 1343 (2016).","DOI":"10.3390\/molecules21101343"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Wang J, Gu BJ, Masters CL, Wang YJ. A systemic view of Alzheimer disease-insights from amyloid-\u03b2 metabolism beyond the brain. Nat. Rev. Neurol.<\/i>, 13<\/b>, 612\u2013623 (2017).","DOI":"10.1038\/nrneurol.2017.111"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Iijima-Ando K, Hearn SA, Granger L, Shenton C, Gatt A, Chiang HC, Hakker I, Zhong Y, Iijima K. Overexpression of neprilysin reduces Alzheimer amyloid-beta42 (Abeta42)-induced neuron loss and intraneuronal Abeta42 deposits but causes a reduction in cAMP-responsive element-binding protein-mediated transcription, age-dependent axon pathology, and premature death in Drosophila.<\/i> J. Biol. Chem.<\/i>, 283<\/b>, 19066\u201319076 (2008).","DOI":"10.1074\/jbc.M710509200"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Grimm MO, Mett J, Stahlmann CP, Grosgen S, Haupenthal VJ, Blumel T, Hundsdorfer B, Zimmer VC, Mylonas NT, Tanila H, Muller U, Grimm HS, Hartmann T. APP intracellular domain derived from amyloidogenic \u03b2- and \u03b3-secretase cleavage regulates neprilysin expression. Front. Aging Neurosci.<\/i>, 7<\/b>, 77 (2015).","DOI":"10.3389\/fnagi.2015.00077"},{"key":"38","unstructured":"38) Marr RA, Hafez DM. Amyloid-beta and Alzheimer\u2019s disease: the role of neprilysin-2 in amyloid-beta clearance. Front. Aging Neurosci.<\/i>, 6<\/b>, 187 (2014)."}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/5\/43_b19-00720\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T06:33:21Z","timestamp":1588833201000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/5\/43_b19-00720\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,1]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b19-00720","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,1]]}}}